Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · IEX Real-Time Price · USD
3.530
+0.220 (6.65%)
At close: Jun 21, 2024, 4:00 PM
3.528
-0.002 (-0.06%)
After-hours: Jun 21, 2024, 4:16 PM EDT

Lisata Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022202120202019 2018 - 1995
Net Income
-20.84-54.23-27.47-8.15-19.36
Upgrade
Depreciation & Amortization
0.190.070.060.060.07
Upgrade
Share-Based Compensation
2.042.642.011.271.3
Upgrade
Other Operating Activities
-1.4230.353.16-2-0.88
Upgrade
Operating Cash Flow
-20.03-21.17-22.25-8.82-18.88
Upgrade
Capital Expenditures
0-0.29-0.06-0.020
Upgrade
Acquisitions
0-3.32000
Upgrade
Change in Investments
10.132.52-54.84-7.2621.43
Upgrade
Investing Cash Flow
10.128.91-54.9-7.2821.43
Upgrade
Share Issuance / Repurchase
0.480.0485.5218.731.31
Upgrade
Other Financing Activities
-0.09-0.27-0.25-0.15-0.13
Upgrade
Financing Cash Flow
0.39-0.2285.2818.581.18
Upgrade
Exchange Rate Effect
-0.02-0.01000
Upgrade
Net Cash Flow
-9.567.518.142.483.73
Upgrade
Free Cash Flow
-20.03-21.46-22.31-8.84-18.88
Upgrade
Free Cash Flow Per Share
-2.48-4.14-6.05-8.59-27.43
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).